Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HANBIN ZHENG

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1154497642
CMS profile
52554
Location
NEW YORK, NY

General Payments · PY2018–2024

$12,927.27

  • Reported across 356 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$248.01

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $248.01 12

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $195.22 9
Acerta Pharma LLC $38.37 2
GlaxoSmithKline, LLC. $14.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,882.46 107
PY2019 $3,580.73 154
PY2020 $2,297.05 32
PY2021 $1,544.91 27
PY2022 $267.13 19
PY2023 $106.98 5
PY2024 $248.01 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $24.06 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105643000 CMS
AstraZeneca Pharmaceuticals LP $14.31 10/02/2024 Food and Beverage Undisputed 01/23/2026 1104322814 CMS
Gilead Sciences, Inc. $23.52 04/11/2024 Food and Beverage Undisputed 01/23/2026 1133752649 CMS
Gilead Sciences, Inc. $28.85 05/02/2024 Food and Beverage Undisputed 01/23/2026 1133752651 CMS
Gilead Sciences, Inc. $7.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 1133752653 CMS
Gilead Sciences, Inc. $8.61 06/20/2024 Food and Beverage Undisputed 01/23/2026 1133752655 CMS
Gilead Sciences, Inc. $24.32 07/11/2024 Food and Beverage Undisputed 01/23/2026 1133752657 CMS
Gilead Sciences, Inc. $9.71 07/18/2024 Food and Beverage Undisputed 01/23/2026 1133752659 CMS
Gilead Sciences, Inc. $33.33 09/27/2024 Food and Beverage Undisputed 01/23/2026 1133752661 CMS
Gilead Sciences, Inc. $31.82 10/25/2024 Food and Beverage Undisputed 01/23/2026 1133752663 CMS
Gilead Sciences, Inc. $27.28 11/20/2024 Food and Beverage Undisputed 01/23/2026 1133752665 CMS
GlaxoSmithKline, LLC. $14.42 05/20/2024 Food and Beverage Undisputed 01/23/2026 1116178246 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.